Formulation And Optimization Of Process Parameters Of Omeprazole DR Pallets: A Case Study For Yield Improvement - Couverture souple

Allamneni, Yaswanth; Padala, Dayananda Chary; Allamneni, Navya

 
9783659251764: Formulation And Optimization Of Process Parameters Of Omeprazole DR Pallets: A Case Study For Yield Improvement
Couverture souple
ISBN 10 : 3659251763 ISBN 13 : 9783659251764
Editeur : LAP LAMBERT Academic Publishing, 2012

Synopsis

The main aim of the present investigation was to observe the entire manufacturing process and to find out the problems occurring during each step of the process and to rectify those. The study involves the improvement in yield by changing (or) rectifying the problems occurred in machine, man, method, material by keeping in mind various formulation aspects relating to it. Omeprazole is prototype member of new class of substituted Benzimidazoles, which inhibits the final common step in gastric acid secretion. In the present investigation, various formulation aspects were studied for developing a pharmaceutical equivalent, stable, cost improved and quality improved formulation of enteric coated omeprazole pellets comparable with innovator and optimize certain process parameters to get maximum yield of the product during large scale manufacturing. The basic goal of drug therapy is to achieve a steady blood or tissue level of the drug at specific site which will be therapeutically effective and non-toxic.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

The main aim of the present investigation was to observe the entire manufacturing process and to find out the problems occurring during each step of the process and to rectify those. The study involves the improvement in yield by changing (or) rectifying the problems occurred in machine, man, method, material by keeping in mind various formulation aspects relating to it. Omeprazole is prototype member of new class of substituted Benzimidazoles, which inhibits the final common step in gastric acid secretion. In the present investigation, various formulation aspects were studied for developing a pharmaceutical equivalent, stable, cost improved and quality improved formulation of enteric coated omeprazole pellets comparable with innovator and optimize certain process parameters to get maximum yield of the product during large scale manufacturing. The basic goal of drug therapy is to achieve a steady blood or tissue level of the drug at specific site which will be therapeutically effective and non-toxic.

Biographie de l'auteur

Working as Executive at Research and Development Department (Technology Transfer) in Natco Pharma Limited. Stood college first in M. Pharmacy under West Bengal University of Technology,West Bengal. Published various Research and Review article in National and International journals.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2012
Langue
anglais
ISBN 10 
3659251763
ISBN 13 
9783659251764
Reliure
Broché
Nombre de pages
72
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne